
Switching Medications: What to Do if Crohn’s Disease Treatment Isn’t Working
It’s possible to achieve remission if you have Crohn’s disease, but it isn’t always easy to find a treatment that will help you get there.
3 Reasons to Switch Medications for Crohn’s
1. You’re No Longer Responding to the Medication
“Many people with Crohn’s disease switch medications because a drug that once worked well gradually stops controlling their symptoms or inflammation — a problem doctors call ‘loss of response,’” says Dr. Moss.
In some cases, symptoms may lessen, but tests could still reveal that the inflammation isn’t under control. “Even though a patient may be feeling well, the gastroenterologist may occasionally recommend switching medications to achieve improved control of inflammation, if still present,” says Limketkai.

2. You’re Having Side Effects
It’s not uncommon to experience side effects, such as abdominal pain, loss of appetite, or nausea. Tell your doctor about any you’re having. They can possibly adjust the dose or suggest a different treatment that may reduce these symptoms, says Limketkai. If you’re on certain medications, your doctor will monitor you for side effects to catch them early, especially complications such as bone marrow problems and liver or pancreas irritation from immunomodulators.

3. Your Insurance Has Changed
Your new insurance plan might require you to switch medications, your prescription coverage may have changed, or your copay costs might skyrocket, says Moss.
Many medication manufacturers offer patient assistance programs that help offset some of the cost, Limketkai says. You can search for the medication you take on a list of assistance programs on the Crohn’s & Colitis Foundation website. There are also available biosimilars (generic versions of biologics) that may be covered by your insurance plan instead.

Assess Your Crohn’s Disease Treatment
Should You Switch Crohn’s Medications?

Treatment Options for Crohn’s Disease
5 Treatment Changes Your Doctor May Recommend

If you decide to make some changes, your doctor may recommend that you:
- Adjust the dose. Increasing the dose or how often you take or get a specific medicine may help better manage symptoms, says Moss.
- Add a partner drug. Sometimes an additional medication can help the primary treatment work better. You might take this temporarily or over the long term, says Limketkai.
- Switch within the same drug family. Sometimes one type of medication in the same broad category of treatments may work better than another. For example, you might change from one tumor necrosis factor–alpha inhibitor (called anti-TNFs or biologics) to another and see an improvement, says Moss.
- Switch to a different class of medication. Your doctor might suggest an entirely new kind of medicine, Moss says. If you’re currently taking an anti-inflammatory corticosteroid but not getting relief, for example, it may be time to try a biologic, which targets specific proteins.
- Opt for surgery. If medications don’t work to control symptoms or you’re having other complications, your doctor may suggest surgical procedures that can remove the inflamed areas of the intestines.
Treatments for Crohn’s Disease

- Corticosteroids Often simply called steroids, these anti-inflammatory drugs are considered a first-line treatment for Crohn’s. Many people with mild disease can achieve remission with steroids alone. These meds are only used for short-term treatment, because they can cause significant side effects. Corticosteroids that are commonly used to manage Crohn’s include budesonide (which targets the gastrointestinal tract more) and prednisone, which can be taken orally.
- Immunomodulators These medications tamp down the immune system’s activity, which can help reduce inflammation. Options such as azathioprine, mercaptopurine, and methotrexate are often used in combination with other Crohn’s medications to help them work better. Immunomodulators can be taken orally or injected.
- Biologics and Biosimilars Biologics, such as adalimumab, certolizumab pegol, and infliximab, are lab-created antibodies that target the proteins that cause Crohn’s-related inflammation. Biosimilars, such as infliximab-dyyb, are nearly identical versions of biologics that have been created to lower medication costs. Both options are administered via infusion or injection and are sometimes used with immunomodulators, too.
- Janus Kinase (JAK) Inhibitors JAK inhibitors (tofacitinib and upadacitinib) block enzymes involved in the overactive immune response of Crohn’s disease. They’re usually used when other treatments don’t help.
- Diet Changes Watching what you eat isn’t a cure for Crohn’s, but it’s an essential part of managing symptoms. Bland, soft foods are less likely to cause flares than high-fiber, spicy foods. When you’re dealing with symptoms such as diarrhea, you’re also losing more fluids, minerals, and vitamins than normal, so do your best to replace what you’ve lost by eating a balanced, nutrient-dense diet.
- Surgery If medications don’t help and inflammation or other complications persist, surgery may be an option. Typically, the affected parts of the intestines are removed, and the healthy parts are joined together.
How to Talk to Your Doctor About Changing Treatments for Crohn’s
Remember, you and your doctor are partners in this decision. Moss says it’s okay to ask questions like, “If we decide to switch, what are the risks, benefits, and realistic expectations with the next option?”
Review this list before your next appointment to have an honest, productive conversation with your doctor about what’s next.
8 Things to Tell Your Doctor

- How you’re really feeling day-to-day, including any fatigue, pain, or urgency you’re experiencing
- How well you’re able to perform at work or school
- Any medication side effects you’re having
- Any new symptoms that have started
- Any trouble taking medications as prescribed
- Any concerns about affording the medications
- How often you miss a dose
- Any changes in your priorities or treatment goals, such as avoiding steroids, planning a pregnancy, or wanting fewer infusion visits
5 Tips for Switching Crohn’s Treatments Successfully
The Bottom Line About Switching Treatments
- Pellegrini G et al. Single and Multiple Switches, Swap and Retransitioning Among 28,073 Biological Drug Users With Inflammatory Bowel Diseases: Results From the Italian VALORE Network. Therapeutic Advances in Gastroenterology. September 28, 2025.
- Fact Sheet: Biologics. Crohn’s & Colitis Foundation. October 2022.
- Regueiro M et al. Overview of the Medical Management of Mild (Low Risk) Crohn Disease in Adults. UpToDate. July 28, 2025.
- Medication Options for Crohn’s Disease. Crohn’s & Colitis Foundation.
- Lichtenstein GR. Treatment of Crohn Disease in Adults: Dosing and Monitoring of Tumor Necrosis Factor-Alpha Inhibitors. UpToDate. October 14, 2025.
- Crohn’s Disease Treatment Options. Crohn’s & Colitis Foundation.
- Gattoni MF et al. The Role of Mastery in Crohn’s Disease: A Cross-Sectional Study. Therapeutic Advances in Gastroenterology. February 19, 2025.
- Barnes E et al. P027 Factors Associated With Biologic Discontinuation in Patients With Inflammatory Bowel Disease in TARGET-IBD. The American Journal of Gastroenterology. December 2020.
- Understanding IBD Medications and Side Effects. Crohn’s & Colitis Foundation. July 2020.
- Crohn’s Disease Diagnosis & Treatment. Mayo Clinic. December 4, 2025.
- Lee KR et al. Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management. Pharmaceutics. November 9, 2024.

Yuying Luo, MD
Medical Reviewer
Yuying Luo, MD, is an assistant professor of medicine at Mount Sinai West and Morningside in New York City. She aims to deliver evidence-based, patient-centered, and holistic care for her patients.
Her clinical and research focus includes patients with disorders of gut-brain interaction such as irritable bowel syndrome and functional dyspepsia; patients with lower gastrointestinal motility (constipation) disorders and defecatory and anorectal disorders (such as dyssynergic defecation); and women’s gastrointestinal health.
She graduated from Harvard with a bachelor's degree in molecular and cellular biology and received her MD from the NYU Grossman School of Medicine. She completed her residency in internal medicine at the Icahn School of Medicine at Mount Sinai, where she was also chief resident. She completed her gastroenterology fellowship at Mount Sinai Hospital and was also chief fellow.

Sarah Klein
Author
Sarah Klein is a Boston-based health journalist with more than 15 years experience in lifestyle media. She has held staff positions at Livestrong, Health, Prevention, and Huffington Post. She is a graduate of the Arthur L. Carter Journalism Institute at New York University, and a National Academy of Sports Medicine–certified personal trainer. She moderated a panel on accessibility in fitness at SXSW in 2022, completed the National Press Foundation’s 2020 Vaccine Boot Camp, and attended Mayo Clinic’s Journalist Residency in 2019.